Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Weiyu Wang, Yufan Ying, Haiyun Xie, Jiangfeng Li, Xueyou Ma, Liujia He, Mingjie Xu, Shiming Chen, Haixiang Shen, Xiangyi Zheng, Ben Liu, Xiao Wang & Liping Xie. (2021) miR-665 inhibits epithelial-to-mesenchymal transition in bladder cancer via the SMAD3/SNAIL axis. Cell Cycle 20:13, pages 1242-1252.
Read now
Read now
Sinthyia Ahmed, Nazrul Islam, Md Shahinozzaman, Sayo O. Fakayode, Nadia Afrin & Mohammad A. Halim. (2021) Virtual screening, molecular dynamics, density functional theory and quantitative structure activity relationship studies to design peroxisome proliferator-activated receptor-γ agonists as anti-diabetic drugs. Journal of Biomolecular Structure and Dynamics 39:2, pages 728-742.
Read now
Read now
Makito Miyake, Takuya Owari, Shunta Hori, Yasushi Nakai & Kiyohide Fujimoto. (2018) Emerging biomarkers for the diagnosis and monitoring of urothelial carcinoma. Research and Reports in Urology 10, pages 251-261.
Read now
Read now
Huaqing Yan, Yufan Ying, Haiyun Xie, Jiangfeng Li, Xiao Wang, Liujia He, Ke Jin, Jianer Tang, Xin Xu & Xiangyi Zheng. (2018) Secondhand smoking increases bladder cancer risk in nonsmoking population: a meta-analysis. Cancer Management and Research 10, pages 3781-3791.
Read now
Read now
Huaqing Yan, Jiangfeng Li, Yufan Ying, Haiyun Xie, Hong Chen, Xin Xu & Xiangyi Zheng. (2018) MIR-300 in the imprinted DLK1-DIO3 domain suppresses the migration of bladder cancer by regulating the SP1/MMP9 pathway. Cell Cycle 17:24, pages 2790-2801.
Read now
Read now
Articles from other publishers (16)
Kamlesh Khunti, Mussa Almalki, Juliana C. N. Chan & Aslam Amod. (2023) The Role of Real-World Evidence in Treatment Decision-Making, Regulatory Assessment, and Understanding the Perspectives of People with Type 2 Diabetes: Examples with Gliclazide MR. Diabetes Therapy 14:10, pages 1609-1625.
Crossref
Crossref
Christopher D. Gaffney, Andrew Katims, Neeta D'Souza, Marc A. Bjurlin & Richard S. Matulewicz. (2023) Bladder Cancer Carcinogens: Opportunities for Risk Reduction. European Urology Focus 9:4, pages 575-578.
Crossref
Crossref
Niyati Lobo, Luca Afferi, Marco Moschini, Hugh Mostafid, Sima Porten, Sarah P. Psutka, Shilpa Gupta, Angela B. Smith, Stephen B. Williams & Yair Lotan. (2022) Epidemiology, Screening, and Prevention of Bladder Cancer. European Urology Oncology 5:6, pages 628-639.
Crossref
Crossref
Georgios S. Papaetis. (2022) Pioglitazone, Bladder Cancer, and the Presumption of Innocence. Current Drug Safety 17:4, pages 294-318.
Crossref
Crossref
Róbert János Bánhegyi, Andrea Gazdag, Beatrix Rácz, László Szalai, Róbert Wágner & Norbert Fülöp. (2022) Onkodiabetológia II.. Orvosi Hetilap 163:40, pages 1575-1584.
Crossref
Crossref
Wah‐Kheong Chan, Soek‐Siam Tan, Siew‐Pheng Chan, Yeong‐Yeh Lee, Hoi‐Poh Tee, Sanjiv Mahadeva, Khean‐Lee Goh, Anis Safura Ramli, Feisul Mustapha, Nik Ritza Kosai & Raja Affendi Raja Ali. (2022) Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction‐associated fatty liver disease. Journal of Gastroenterology and Hepatology 37:5, pages 795-811.
Crossref
Crossref
Cristina Rey-Reñones, Jose Miguel Baena-Díez, Isabel Aguilar-Palacio, Cristina Miquel & María Grau. (2021) Type 2 Diabetes Mellitus and Cancer: Epidemiology, Physiopathology and Prevention. Biomedicines 9:10, pages 1429.
Crossref
Crossref
Jaehyun Bae, Taegyun Park, Hyeyoung Kim, Minyoung Lee & Bong-Soo Cha. (2021) Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus. Diabetes & Metabolism Journal 45:3, pages 326-336.
Crossref
Crossref
Montserrat García, Unai Arteche‐Martinez, Unax Lertxundi & Carmelo Aguirre. (2020) SGLT2 Inhibitors and Bladder Cancer: Analysis of Cases Reported in the European Pharmacovigilance Database. The Journal of Clinical Pharmacology 61:2, pages 187-192.
Crossref
Crossref
Shawn Dason & Nathan C. Wong. 2021. Comprehensive Diagnostic Approach to Bladder Cancer. Comprehensive Diagnostic Approach to Bladder Cancer
13
44
.
Erika Aparecida Silveira, Golnaz Vaseghi, Annelisa Silva de Carvalho Santos, Nathalie Kliemann, Farzad Masoudkabir, Matias Noll, Noushin Mohammadifard, Nizal Sarrafzadegan & Cesar de Oliveira. (2020) Visceral Obesity and Its Shared Role in Cancer and Cardiovascular Disease: A Scoping Review of the Pathophysiology and Pharmacological Treatments. International Journal of Molecular Sciences 21:23, pages 9042.
Crossref
Crossref
Varsha MishraGanesh Balasubramaniam. (2020) Urinary bladder cancer and its associated factors – An epidemiological overview. Indian Journal of Medical Sciences 73, pages 239-248.
Crossref
Crossref
Haihong Chen, Qixing Nie, Jielun Hu, Xiaojun Huang, Wenqi Huang & Shaoping Nie. (2020) Metabolism amelioration of Dendrobium officinale polysaccharide on type II diabetic rats. Food Hydrocolloids 102, pages 105582.
Crossref
Crossref
Yuzuru Iizuka, Kanako Chiba, Hyounju Kim, Satoshi Hirako, Masahiro Wada & Akiyo Matsumoto. (2020) Impact of discontinuation of fish oil after pioglitazone–fish oil combination therapy in diabetic KK mice. The Journal of Nutritional Biochemistry 76, pages 108265.
Crossref
Crossref
Jianjian Xiang, Huaqing Yan, Jiangfeng Li, Xiao Wang, Hong Chen & Xiangyi Zheng. (2019) Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis. World Journal of Surgical Oncology 17:1.
Crossref
Crossref
Joseph M. Pappachan, Cornelius J. Fernandez & Elias C. Chacko. (2019) Diabesity and antidiabetic drugs. Molecular Aspects of Medicine 66, pages 3-12.
Crossref
Crossref